Researchers have discovered a new class of broad-spectrum antiviral compounds that amplify a cell's natural defenses against viruses. These compounds activate the integrated stress response pathway, boosting the cell's ability to fight off infections. Testing on human cells and mice showed effectiveness against Zika, herpes, and RSV viruses. The compounds only activate in infected cells, minimizing side effects. Further research aims to advance these compounds towards clinical trials.

Prepared by Olivia Bennett and reviewed by editorial team.